Skip to content

Inspire Medical Systems

US · INSP #2781 by market cap Listed 2018
67.45 -0.75 -1.10%
Live - 5344 symbols - heartbeat 406s ago · 2026-10-07 19:54
After-hours 67.45 0.00%
Market cap
1.95B
P/B
2.36
EPS
4.89
Reader sentiment Are you bullish or bearish on INSP?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 14 analysts

Hold
Avg price target 64.77 -4.0%
Price target rangecurrent 67.45
Low39.00
Avg64.77
High97.00
Buy 29% Hold 57% Sell 14%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-01 RBC Capital -- HOLD 75.00
2026-09-22 Stifel -- BUY 85.00
2026-09-21 Freedom Capital Markets -- BUY 97.00
2026-09-13 Stifel -- BUY 80.00
2026-09-11 Stifel -- BUY 80.00
2026-08-04 Wells Fargo -- HOLD 56.00
2026-08-04 Mizuho Securities -- BUY 65.00
2026-08-04 Piper Sandler -- HOLD 60.00
2026-08-04 KeyBanc -- HOLD --
2026-08-04 BofA Securities -- SELL 45.00
2026-08-04 Truist Financial -- HOLD 62.00
2026-08-04 Baird -- HOLD 59.00
2026-08-04 Evercore -- HOLD 54.00
2026-08-04 Stifel -- BUY 75.00
2026-08-04 Oppenheimer -- BUY 85.00
2026-08-04 J.P. Morgan -- HOLD 60.00
2026-07-28 UBS -- SELL 39.00
2026-07-16 Truist Financial -- HOLD 54.00
2026-07-02 Wells Fargo -- HOLD 56.00
2026-06-30 Freedom Capital Markets -- BUY 62.00
2026-05-22 BofA Securities -- SELL 39.00
2026-05-15 BofA Securities -- HOLD 53.00
2026-05-07 Oppenheimer -- HOLD --
2026-05-05 Wells Fargo -- HOLD 56.00
2026-05-05 Mizuho Securities -- BUY 55.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Sell
Analyst consensus
Hold

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
1 11
■ Upgrades■ Downgrades
  • 1 upgrade vs 11 downgrades among tracked analyst rating changes.
  • Most recent: Evercore moved from Buy to Hold on 2026-08-04.

Recent rating changes

DateFirmChangeTarget
2026-08-04 Evercore BUY → HOLD 54.00
2026-08-04 Oppenheimer HOLD → BUY 85.00
2026-07-28 UBS HOLD → SELL 39.00
2026-05-22 BofA Securities HOLD → SELL 39.00
2026-05-15 BofA Securities BUY → HOLD 53.00
2026-05-05 Piper Sandler BUY → HOLD 55.00
2026-02-13 Wolfe Research BUY → HOLD --
2026-02-12 Baird BUY → HOLD 74.00
2026-02-11 Wells Fargo BUY → HOLD 70.00
2026-01-26 RBC Capital BUY → HOLD 90.00
2026-01-22 Oppenheimer BUY → HOLD --
2026-01-21 Truist Financial BUY → HOLD 96.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-08-03 After close ±12.35% +22.83% (beat)
2026/Q1 2026-05-04 After close ±16.13% -12.02% (in line)
2025/Q4 2026-02-11 After close ±12.14% -12.55% (beat)
2025/Q3 2025-11-03 After close ±16.18% +15.33% (in line)
2025/Q2 2025-08-04 After close ±15.60% -32.35% (beat)
2025/Q1 2025-05-05 After close ±13.25% +1.98% (in line)
2024/Q4 2025-02-10 After close ±12.41% +1.66% (in line)
2024/Q3 2024-11-04 After close ±16.06% +3.26% (in line)
2024/Q2 2024-08-06 After close ±15.05% +28.14% (beat)
2024/Q1 2024-05-07 After close ±9.36% -33.47% (beat)
2023/Q4 2024-02-06 After close ±10.11% -10.55% (beat)
2023/Q3 2023-11-07 After close ±17.09% -19.66% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.